Double-Negative T (DNT) Cells in Patients with Systemic Lupus Erythematosus

Area of Science:

• Immunology
• Rheumatology

Background:

• Double-negative T (DNT) cells are an unconventional T-lymphocyte subset lacking CD4 and CD8 markers.
• Their immunopathological roles remain largely unclear, though they are implicated in autoimmune lymphoproliferative syndrome (ALPS).
• DNT cells may contribute to rheumatic disorders like systemic lupus erythematosus (SLE), sharing autoimmune manifestations such as nephritis.

Purpose of the Study:

• To review and analyze clinical studies on DNT cell populations in SLE patients.
• To elucidate the potential role of DNT cells in SLE pathogenesis.
• To explore DNT cells as potential disease markers or therapeutic targets in SLE.

Main Methods:

• Literature review and analysis of clinical studies involving DNT cells in SLE patients (adults and children).
• Examination of DNT cell homeostasis and percentage in relation to disease activity and inflammatory parameters.

Main Results:

• DNT cell homeostasis appears altered in SLE patients, with most studies reporting increased DNT cell percentages.
• Elevated DNT cell counts were particularly noted during active phases of SLE.
• A clear correlation between DNT cell levels and disease activity or inflammatory markers was not definitively established.

Conclusions:

• DNT cell alterations are observed in SLE patients, suggesting a potential role in the disease.
• Standardized, longitudinal studies are necessary to confirm the immunopathological relevance of DNT cells in SLE.
• Further investigation is needed to determine if DNT cells are pathogenic contributors, potential biomarkers, or merely an epiphenomenon in SLE.